+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "DNA Vaccines"

From
DNA Vaccines - Global Strategic Business Report - Product Thumbnail Image

DNA Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 171 Pages
  • Global
From
From
From
From
Multivalent Influenza Vaccines Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030 - Product Thumbnail Image

Multivalent Influenza Vaccines Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • Report
  • August 2025
  • 194 Pages
  • United States, Global United States, Global
From
From
Loading Indicator

DNA vaccines are a type of genomics-based vaccine that uses genetic material from a virus or bacteria to stimulate an immune response. They are created by introducing a gene that codes for a specific antigen into a plasmid, which is then inserted into a host cell. The host cell then produces the antigen, which is then used to stimulate an immune response. DNA vaccines are considered to be safer than traditional vaccines, as they do not contain any live virus or bacteria. Additionally, they can be produced more quickly and cheaply than traditional vaccines. DNA vaccines have been used to treat a variety of diseases, including influenza, malaria, and HIV. They have also been used to develop vaccines for cancer and other diseases. Recently, DNA vaccines have been used to develop vaccines for the prevention of infectious diseases, such as Zika virus and Ebola. Companies in the DNA Vaccines market include Moderna, Inovio Pharmaceuticals, Novavax, and Transgene. Show Less Read more